We have located links that may give you full text access.
The MR Imaging Appearance of Endoscopic Endonasal Skull Base Defect Reconstruction Using Free Mucosal Graft.
World Neurosurgery 2019 Februrary 20
OBJECTIVE: At our institution, skull base reconstruction using a free mucosal graft from the nasal cavity floor has been the standardized technique after pituitary adenoma resection via transsellar approach. This study describes the expected appearance of the reconstruction on postoperative MRI scans and assesses its integrity and impact on the sinonasal cavity.
METHODS: Fifty patients were selected, and their EMR were reviewed for postoperative course, SNOT-22 scores, and nasal endoscopy reports. A total of 116 postoperative MRI scans were available to evaluate 1) the appearance and thickness of the graft, 2) the enhancement of the graft, and 3) the T2 signal in sphenoid sinus as a potential indication for inflammatory disease.
RESULTS: There was no significant change in the thickness of the graft over time. Except for the 7 scans that were obtained without IV contrast, all scans showed enhancement of the graft. About half of the patients displayed persistent T2 hyperintense signal at 12 and 24 months. However, this was not clinically significant, as postoperative SNOT-22 scores demonstrated minimal sinonasal impact.
CONCLUSION: Postoperative MRI surveillance scans demonstrated a stable appearance of the graft that mimics the native mucosa, with enhancement through time, reflecting its robust vascularization and well integration to the skull base. Although persistent T2 hyperintense signal was detected in the sphenoid sinus, clinical evidence based on nasal endoscopy reports and SNOT-22 scores indicated minimal sinonasal morbidity.
METHODS: Fifty patients were selected, and their EMR were reviewed for postoperative course, SNOT-22 scores, and nasal endoscopy reports. A total of 116 postoperative MRI scans were available to evaluate 1) the appearance and thickness of the graft, 2) the enhancement of the graft, and 3) the T2 signal in sphenoid sinus as a potential indication for inflammatory disease.
RESULTS: There was no significant change in the thickness of the graft over time. Except for the 7 scans that were obtained without IV contrast, all scans showed enhancement of the graft. About half of the patients displayed persistent T2 hyperintense signal at 12 and 24 months. However, this was not clinically significant, as postoperative SNOT-22 scores demonstrated minimal sinonasal impact.
CONCLUSION: Postoperative MRI surveillance scans demonstrated a stable appearance of the graft that mimics the native mucosa, with enhancement through time, reflecting its robust vascularization and well integration to the skull base. Although persistent T2 hyperintense signal was detected in the sphenoid sinus, clinical evidence based on nasal endoscopy reports and SNOT-22 scores indicated minimal sinonasal morbidity.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app